MYMEDS&ME
LIVE

Serial Number

79138122

Owner

MyMedsandMe Limited

Attorney

Cynthia A. Moyer

Filing Date

Feb 15, 2013

Add to watchlist:

No watchlists yet
View on USPTO

MYMEDS&ME Trademark

Serial Number: 79138122 • Registration: 4607742

MYMEDS&ME is a trademark filed by MyMedsandMe Limited on February 15, 2013. The trademark is classified under Class 9 (Computers & Electronics), Class 38 (Telecommunications), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

MyMedsandMe Limited (4 trademarks)

2 Crossways Business Centre
Aylesbury, HP18 0RA , GB

Entity Type: 99

Trademark Details

Filing Date

February 15, 2013

Registration Date

September 23, 2014

Published for Opposition

July 8, 2014

Cancellation Date

March 6, 2026

Goods & Services

software as a service (SAAS) services featuring software for capturing and providing data concerning the quality of medication and/or pharmaceuticals, reactions and events resulting from the use of medication and/or pharmaceuticals, for enabling follow up questions and answers regarding said reactions and events and for producing reports regarding such quality, reactions and events; software as a service (SAAS) services featuring software for evaluating and analysing data and information concerning the quality of medication and/or pharmaceuticals and the reactions and events resulting from the use of medication or pharmaceuticals; providing temporary use of on-line non-downloadable software which enables the capture of information concerning the quality of medication and/or pharmaceuticals, reactions and events resulting from the use medication and/or pharmaceuticals, as well as enabling followup questions and answers regarding said quality, reactions and events and enables the production of reports regarding said reactions and events; services for maintenance of computer software; providing temporary use of non-downloadable software allowing web site users to send and receive information concerning the quality of medication and/or pharmaceuticals used, reactions and events resulting from the use of medication and/or pharmaceuticals, answer (and read answers to) follow-up questions regarding said quality, reactions and events and produce reports regarding said reactions and events; software as a service (SAAS) services featuring software for collecting, evaluating and analysing data concerning the quality of medication and/or pharmaceuticals used, reactions and events resulting from the use of medication and/or pharmaceuticals

computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of data and information concerning the quality, safety and effectiveness of medications and/or pharmaceuticals and reactions and events resulting from the use of medications and/or pharmaceuticals; computer software for capturing and providing information concerning quality of medication and/or pharmaceuticals and reactions and events resulting from the use of medication and/or pharmaceuticals, enabling follow-up questions and answers regarding said quality, reactions and events and producing reports regarding such quality, reactions and events; computer programs for capturing and providing information concerning the quality of medication and/or pharmaceuticals and reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said quality, reactions and events and for producing reports regarding such quality, reactions and events; computer software applications for capturing information concerning the quality of medication and/or pharmaceuticals, reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said reactions and events and for producing reports regarding such quality, reactions and events; computer software for the evaluation and analysis of data and information concerning the quality, safety and effectiveness of medication and/or pharmaceuticals and the reactions and events resulting from the use of medication and/or pharmaceuticals

Telecommunications services, namely, transmission of data by means of telecommunications networks, wireless communication networks and the Internet; telecommunication services for providing multiple user access to a global network; transfer of data by telecommunication; transmission and reception of database information via telecommunications networks; data transmission and reception services via telecommunications means; providing telecommunications connections to databases; electronic exchange of data stored in databases accessible via telecommunication networks; communication services, namely, providing electronic transmission of information stored in a database via interactively communicating computer systems; providing multiple use access to global computer information networks for the transfer and dissemination of a wide range of information; information transmission via electronic communications networks; providing multiple user access to proprietary collections of information by means of global computer information networks; telecommunication services, namely, electronic exchange of medical records between patients or health care professionals and pharmaceutical companies; telecommunication services, namely, providing access to an electronic exchange of medical records between patients or health care professionals and pharmaceutical companies

Filing History

CANCELLED SECTION 71
Mar 6, 2026 C71T
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Sep 23, 2023 REM4
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 21, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 21, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 21, 2023 REAP
INTERNATIONAL REGISTRATION RENEWED
Feb 3, 2023 RNWL
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
May 12, 2021 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
May 12, 2021 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 5, 2021 APRE
TEAS SECTION 71 & 15 RECEIVED
Sep 23, 2020 ES75
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 13, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 26, 2015 FICS
FINAL DISPOSITION PROCESSED
Feb 26, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 23, 2014 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 23, 2014 R.PR
NOTIFICATION PROCESSED BY IB
Jul 22, 2014 GPNX
PUBLISHED FOR OPPOSITION
Jul 8, 2014 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 2, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 2, 2014 OP2R
NOTICE OF PUBLICATION
Jun 18, 2014 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 31, 2014 PREV
ASSIGNED TO LIE
May 31, 2014 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 19, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 16, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 15, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 15, 2014 TROA
REFUSAL PROCESSED BY IB
Dec 10, 2013 RFNT
APPLICATION FILING RECEIPT MAILED
Nov 19, 2013 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 15, 2013 RFCS
REFUSAL PROCESSED BY MPU
Nov 14, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 14, 2013 RFCR
NON-FINAL ACTION WRITTEN
Nov 13, 2013 CNRT
ASSIGNED TO EXAMINER
Nov 13, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 13, 2013 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Nov 12, 2013 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 11, 2013 REPR